A 23-year-old woman presents to her physician requesting the chickenpox vaccine. She is also complaining of nausea, malaise, and moderate weight gain. She developed these symptoms gradually over the past 2 weeks. She reports no respiratory or cardiovascular disorders. Her last menstruation was about 6 weeks ago. She has one sexual partner and uses a natural planning method for contraception. Her vital signs include: blood pressure 110/70 mm Hg, heart rate 92/min, respiratory rate 14/min, and temperature 37.2℃ (99℉). The physical examination shows non-painful breast engorgement and nipple hyperpigmentation. There is no neck enlargement and no palpable nodules in the thyroid gland. The urine beta-hCG is positive. What is the proper recommendation regarding chickenpox vaccination in this patient?

Confirm pregnancy with serum beta-hCG and if positive, postpone administration of the vaccine until after completion of the pregnancy.

Confirm pregnancy with serum beta-hCG and if positive delay administration of the vaccine until the third trimester.

Perform varicella viral load and schedule the vaccine based on these results.

Confirm pregnancy with serum beta-hCG and if positive, schedule the patient for pregnancy termination.

A 28-year-old woman presents to her physician for follow-up. She was found to be HIV-positive 9 months ago. Currently she is on ART with lamivudine, tenofovir, and efavirenz. She has no complaints and only reports a history of mild respiratory infection since the last follow-up. She is also allergic to egg whites. Her vital signs are as follows: the blood pressure is 120/75 mm Hg, the heart rate is 73/min, the respiratory rate is 13/min, and the temperature is 36.7°C (98.0°F). She weighs 68 kg (150 lb), and there is no change in her weight since the last visit. On physical examination, she appears to be pale, her lymph nodes are not enlarged, her heart sounds are normal, and her lungs are clear to auscultation. Her total blood count shows the following findings: Erythrocytes 3.2 x 106/mm3 Hematocrit 36% Hgb 10 g/dL Total leukocyte count 3,900/mm3 Neutrophils 66% Lymphocytes 24% Eosinophils 3% Basophils 1% Monocytes 7% Platelet count 280,000/mm3 Her CD4+ cell count is 430 cells/µL. The patient tells you she would like to get an influenza vaccination as flu season is coming. Which of the following statements is true regarding influenza vaccination in this patient?

The patient can receive approved recombinant or inactivated influenza vaccines, with egg-free formulations preferred due to her egg allergy.

As long as the patient is anemic, she should not be vaccinated.

Influenza vaccination is contraindicated in HIV-positive patients because of the serious complications they can cause in immunocompromised people.

Inactivated or recombinant influenza vaccines fail to induce a sufficient immune response in patients with CD4+ cell counts under 500 cells/µL.

Nasal-spray influenza vaccine is the best option for vaccination in this patient.

A 40-year-old pregnant woman, G4 P3, visits your office at week 30 of gestation. She is very excited about her pregnancy and wants to be the healthiest she can be in preparation for labor and for her baby. What vaccination should she receive at this visit?

Tetanus, diphtheria, and acellular pertussis (Tdap)

Measles, mumps, and rubella (MMR)

Live attenuated influenza vaccine

A 35-year-old man is brought to the emergency department by his wife because of a 1-week history of progressive confusion, myalgia, and nausea. His wife says that he first reported headaches and fatigue 10 days ago, and since then “he has not been himself”. He has refused to drink any liquids for the last day. Two months ago, he helped his neighbor remove a raccoon's den from her backyard. He appears agitated. His temperature is 100.8°F (38.2°C). Examination shows excessive drooling. Muscle tone and deep tendon reflexes are increased bilaterally. Administration of which of the following is most likely to have prevented this patient's condition?

Inosine monophosphate dehydrogenase inhibitor

RNA-dependent DNA polymerase inhibitor

Immunoglobulin against a bacterial protein

A 4-month-old boy is brought to the physician by his parents for a well-child examination. He has cystic fibrosis diagnosed by newborn screening. His parents report frequent feedings and large-volume and greasy stools. His 4-year-old brother has autism. Current medications include bronchodilators, pancreatic enzyme supplements, and fat-soluble vitamins. He is at the 18th percentile for height and 15th percentile for weight. Scattered wheezes are heard throughout both lung fields. Examination shows a distended and tympanic abdomen with no tenderness or guarding. Which of the following is a contraindication for administering one or more routine vaccinations?

Fever of 38.2°C (100.7°F) following previous vaccinations

Live vs inactivated vaccines for USMLE Step 2 CK: High-Yield Pediatrics Lessons

Live vs Inactivated - The Great Divide

A fundamental concept distinguishing vaccine types is crucial for understanding schedules, contraindications, and immune response.

Feature	Live Attenuated Vaccines	Inactivated (Killed) Vaccines
Composition	Weakened (attenuated) pathogen	Whole or fractional killed pathogen
Booster Doses	Single dose often sufficient	Multiple doses & boosters needed
Immunity	Humoral & Cellular (IgG, IgA)	Mainly Humoral (IgG)
Durability	Long-lasting, often lifelong	Shorter duration, immunity wanes
Safety	Risk of reversion to virulence	No risk of causing disease
Contraindication	Immunocompromised, Pregnancy	Safe in immunodeficiency
Stability	Less stable (requires cold chain)	More stable
Adjuvant	Not required	Required to enhance immunogenicity

⭐ High-Yield: Live attenuated vaccines produce a strong, long-lasting cellular (T-cell) and humoral (antibody) immune response, mimicking natural infection. Inactivated vaccines primarily stimulate a humoral response.

Live Vaccines - The Attenuated Crew

Mechanism: Weakened (attenuated) but viable organisms that replicate in the host.
Immunity: Potent, long-lasting; stimulates both humoral (IgG, IgA) & cell-mediated immunity. Often single-dose efficacy (exceptions: oral vaccines).
Risks: Potential to revert to virulence; risk of disease in immunocompromised hosts.
Contraindications: Pregnancy, immunodeficiency (e.g., SCID, HIV with CD4 < 200/μL).
Examples: 📌 Roman Is Best Man To Call Your Vacancy: Rotavirus, Influenza (nasal), BCG, Measles, Mumps, Rubella, Typhoid (oral), Cholera (oral), Yellow Fever, Varicella.

⭐ Sabin (Oral Polio Vaccine - OPV) can rarely revert to cause Vaccine-Associated Paralytic Poliomyelitis (VAPP).

Types of vaccines: attenuated, inactivated, viral vector

Inactivated Vaccines - The Killed Squad

Made from whole bacteria/viruses killed by heat or chemicals (e.g., formalin). Cannot replicate or cause disease, making them safer.
Immunity Profile:
- Less immunogenic than live vaccines.
- Require multiple doses & adjuvants (e.g., alum) to boost response.
- Primarily stimulate humoral (antibody) immunity; weak cell-mediated immunity.
- Shorter-lasting immunity, needing booster doses.
📌 Mnemonic: "R.I.P. H.A." → Rabies, Influenza (injectable), Polio (Salk), Hepatitis A.
Examples (Bacterial): Whole-cell Pertussis, Typhoid, Cholera.

⭐ Inactivated vaccines predominantly induce a Th2-mediated response, leading to humoral immunity (antibody production), unlike live vaccines which stimulate a broader Th1 and Th2 response.

Types of Vaccines: Live, Killed, Subunit, Toxoid, mRNA

Contraindications - Handle With Care

Live Vaccines:
- Anaphylaxis to a vaccine component.
- Pregnancy (theoretical risk to fetus).
- Severe immunodeficiency (e.g., SCID, high-dose steroids >2 mg/kg/day for >14 days, chemotherapy).
Inactivated Vaccines:
- Severe anaphylaxis to a previous dose is the only true contraindication.
- Moderate-to-severe illness is a precaution (defer until stable).

⭐ Withhold live vaccines (MMR, Varicella) for 3-11 months after immunoglobulin/blood product administration.

Types of Vaccines: Advantages, Disadvantages, and Examples

High‑Yield Points - ⚡ Biggest Takeaways

Live attenuated vaccines provide stronger, lifelong immunity (Cell-Mediated & Humoral) but risk causing disease in immunocompromised patients.

Inactivated vaccines are safer but offer weaker, shorter-lived immunity (mainly Humoral), requiring multiple doses and boosters.

Live vaccines are generally not given to pregnant women or immunocompromised individuals.

Inactivated vaccines are the preferred choice in pregnancy and immunosuppression.

Antibody interference can affect the efficacy of live vaccines.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play